-
Subject Areas on Research
-
"At home, no one knows": A qualitative study of retention challenges among women living with HIV in Tanzania.
-
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.
-
A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques.
-
A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.
-
A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.
-
A comparison of performance-based measures of function in HIV-associated neurocognitive disorders.
-
A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.
-
A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
-
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.
-
A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro.
-
A randomized controlled trial of health information exchange between human immunodeficiency virus institutions.
-
A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy.
-
A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.
-
A vital role for interleukin-21 in the control of a chronic viral infection.
-
A whole-genome association study of major determinants for host control of HIV-1.
-
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
-
Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.
-
Activity of Galidesivir in a Hamster Model of SARS-CoV-2.
-
Acute HIV-1 infection in the Southeastern United States: a cohort study.
-
Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
-
Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.
-
Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs.
-
Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.
-
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
-
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
-
An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.
-
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
-
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
-
Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.
-
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.
-
Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
-
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation.
-
Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
-
Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
-
Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
-
Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
-
Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.
-
Approach to the treatment-naïve patient with HCV genotype 1 infection.
-
Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee Geneva, 21-23 February 2000.
-
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
-
Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
-
Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.
-
Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.
-
Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
-
Autoimmune hepatitis in a child with chronic hepatitis B virus infection.
-
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.
-
Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV.
-
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response.
-
Boceprevir for untreated chronic HCV genotype 1 infection.
-
Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
-
Brief Report: Blood and Genital Fluid Viral Load Trajectories Among Treated and Untreated Persons With Acute HIV Infection in Malawi.
-
CCL3L1 and HIV/AIDS susceptibility.
-
CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
-
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
-
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
-
CSF, plasma viral load and HIV associated dementia.
-
Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count.
-
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.
-
Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques.
-
Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
-
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
-
Changing antiretroviral therapy in the setting of virologic relapse: review of the current literature.
-
Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
-
Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP).
-
Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.
-
Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.
-
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients.
-
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques.
-
Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
-
Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
-
Common genetic variation and the control of HIV-1 in humans.
-
Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C.
-
Comparative effectiveness of dual vs. single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
-
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.
-
Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals.
-
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
-
Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures.
-
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
-
Construction and characterization of infectious cDNA clones of enterovirus 71 (EV71).
-
Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.
-
Contribution of 3CD Region to the Virulence of Enterovirus 71.
-
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform.
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
-
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
-
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
-
Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
-
Copy number variation of KIR genes influences HIV-1 control.
-
Correlates of Self-Reported Viral Suppression Among HIV-Positive, Young, Black Men Who Have Sex With Men Participating in a Randomized Controlled Trial of An Internet-Based HIV Prevention Intervention.
-
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.
-
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
-
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
-
Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
-
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.
-
Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.
-
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.
-
Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women.
-
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge.
-
DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.
-
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
-
Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.
-
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
-
Defining the rural HIV epidemic: correlations of 3 definitions--South Carolina, 2005-2011.
-
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
-
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
-
Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation.
-
Detection of BK polyomavirus after kidney transplantation: a comparison of urine electron microscopy with plasma polymerase chain reaction.
-
Determination of hepatitis B phenotype using biochemical and serological markers.
-
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
-
Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina.
-
Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation.
-
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy.
-
Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee.
-
Drivers of Inter-individual Variation in Dengue Viral Load Dynamics.
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
-
Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China.
-
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up.
-
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.
-
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.
-
Economic evaluation of ART in resource-limited countries.
-
Editorial comment: renal insufficiency in HIV-infected patients may not always be HIVAN.
-
Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.
-
Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study.
-
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys.
-
Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
-
Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus.
-
Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
-
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.
-
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.
-
Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women.
-
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.
-
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
-
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
-
Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
-
Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
-
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
-
Estimation and prediction with HIV-treatment interruption data.
-
Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.
-
Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6).
-
Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.
-
Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
-
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy.
-
Factors associated with failure to list HIV-positive kidney transplant candidates.
-
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
-
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.
-
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.
-
Focusing HIV prevention on those most likely to transmit the virus.
-
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.
-
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
-
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.
-
Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
-
Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings.
-
Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.
-
HIV and older adults: clinical outcomes in the era of HAART.
-
HIV antibodies for treatment of HIV infection.
-
HIV community viral load trends in South Carolina.
-
HIV heterosexual transmission: a hypothesis about an additional potential determinant.
-
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment.
-
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques.
-
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
-
HIV-1 Drug Resistance and Virologic Outcomes Among Tanzanian Youth Living With HIV.
-
HIV-1 diversity and compartmentalization in urine, semen, and blood.
-
HIV-1 dynamics in haemodialysis patients.
-
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
-
HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
-
Healthcare retention and clinical outcomes among adolescents living with HIV after transition from pediatric to adult care: a systematic review.
-
Hepatic immunopathology during occult hepacivirus re-infection.
-
Hepatitis B virus viral load and treatment decision.
-
Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury.
-
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
-
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.
-
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
-
Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group.
-
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
-
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.
-
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
-
IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
-
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.
-
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.
-
ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.
-
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
-
Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.
-
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
-
Immunization against SIVmne in macaques using multigenic DNA vaccines.
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
-
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy.
-
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.
-
Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.
-
Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression.
-
Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.
-
Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction.
-
Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
-
Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020.
-
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.
-
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
-
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi.
-
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
-
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
-
Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.
-
Influence of HLA-C expression level on HIV control.
-
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
-
Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.
-
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated.
-
Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza: A Clinical Study.
-
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
-
Interactions between highly active antiretroviral therapy and over-the-counter agents: a cautionary note.
-
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
-
Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.
-
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.
-
Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
-
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
-
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
-
Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.
-
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
-
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
-
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
-
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
-
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
-
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
-
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
-
Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain.
-
Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys.
-
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
-
Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.
-
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.
-
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
-
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
-
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
-
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.
-
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.
-
Lost in translation? IL28B's discovery and the journey back to the patient.
-
Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function.
-
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.
-
Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
-
Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
-
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.
-
Memory CD4(+) T lymphocytes in the gastrointestinal tract are a major source of cell-associated simian immunodeficiency virus in chronic nonpathogenic infection of African green monkeys.
-
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
-
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.
-
Mixed model analysis of censored longitudinal data with flexible random-effects density.
-
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
-
Modelling HIV immune response and validation with clinical data.
-
Molecular evaluation of BK polyomavirus nephropathy.
-
Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
-
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.
-
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
-
N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection.
-
Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
-
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
-
Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study.
-
Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.
-
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
-
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
-
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.
-
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.
-
Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.
-
Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study.
-
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults.
-
Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States.
-
Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.
-
Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
-
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.
-
Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.
-
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.
-
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.
-
Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.
-
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
-
Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
-
Physiological and psychosocial factors that predict HIV-related fatigue.
-
Physiological correlates of HIV-related fatigue.
-
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
-
Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.
-
Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationships.
-
Porcine reproductive and respiratory syndrome virus induces pronounced immune modulatory responses at mucosal tissues in the parental vaccine strain VR2332 infected pigs.
-
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge.
-
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.
-
Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys.
-
Prediction of treatment week eight response & sustained virologic response in patients treated with boceprevir plus peginterferon alfa and ribavirin.
-
Predictors of Condomless Anal Intercourse in Young HIV-Positive Men Who Have Sex With Men With Detectable Viral Loads.
-
Predictors of glycaemic control among HIV-positive veterans with diabetes.
-
Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.
-
Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.
-
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.
-
Preexposure prophylaxis for HIV infection among African women.
-
Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
-
Preoperative immune status determines anal condyloma recurrence after surgical excision.
-
Preservation of memory CD4(+) T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection.
-
Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection.
-
Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
-
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States.
-
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.
-
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.
-
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
-
Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States.
-
Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.
-
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
-
Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration.
-
Protection from pathogenic SIV challenge using multigenic DNA vaccines.
-
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
-
Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
-
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
-
Quantifying SARS-CoV-2 viral load: current status and future prospects.
-
Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.
-
Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
-
Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.
-
Recovery of live virus after storage at ambient temperature using ViveST™.
-
Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.
-
Relation of lifetime trauma and depressive symptoms to mortality in HIV.
-
Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients.
-
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.
-
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.
-
Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques.
-
Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women.
-
Review of the use of hepatitis B core antibody-positive kidney donors.
-
RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines.
-
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
-
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
-
Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.
-
Risk of Skin Cancers in Older Persons Living With HIV: A Systematic Review.
-
Risk patterns preceding diagnosis among newly HIV-diagnosed men who have sex with men in New York City.
-
Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases.
-
SARS-CoV-2 viral load is associated with increased disease severity and mortality.
-
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
-
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children.
-
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients.
-
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.
-
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.
-
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
-
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
-
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
-
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
-
Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.
-
Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
-
Sexual behaviour, condom use, and disclosure of HIV status in HIV infected heterosexual individuals attending an inner London HIV clinic.
-
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.
-
Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.
-
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.
-
Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
-
Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
-
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells.
-
Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.
-
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.
-
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults.
-
Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.
-
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
-
Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.
-
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.
-
Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
-
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.
-
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
-
Sustained viral response after interferon-based therapy in chronic hepatitis C: more evidence to support a life-long cure.
-
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity.
-
Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients.
-
Systematic review of the performance of HIV viral load technologies on plasma samples.
-
Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis.
-
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
-
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development.
-
Telaprevir for previously treated chronic HCV infection.
-
Telaprevir for previously untreated chronic hepatitis C virus infection.
-
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
-
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
-
The HIV Care Continuum among Female Sex Workers: A Key Population in Lilongwe, Malawi.
-
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care.
-
The clinical management of HCV in the HIV-infected patient.
-
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.
-
The impact of host immune status on the within-host and population dynamics of antigenic immune escape.
-
The increasing impact of human immunodeficiency virus infections, sexually transmitted diseases, and viral hepatitis in Durham County, North Carolina: a call for coordinated and integrated services.
-
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.
-
The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk.
-
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections.
-
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.
-
The role of HIV-DNA testing in clinical practice.
-
Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation.
-
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques.
-
Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.
-
Timing of retroviral infection influences anamnestic immune response in vaccinated primates.
-
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
-
Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months.
-
Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
-
Transcriptional network predicts viral set point during acute HIV-1 infection.
-
Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.
-
Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load.
-
Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.
-
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
-
Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
-
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
-
Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
-
Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.
-
Understanding of Perceived Infectiousness and Its Influence on Sexual Behavior Among Individuals With Acute HIV Infection in Lilongwe, Malawi (HPTN 062).
-
Undetectable Hepatitis C Viral Load Is Associated With Improved Outcomes Following Total Joint Arthroplasty.
-
Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.
-
Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
-
Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients.
-
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
-
Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
-
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.
-
Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans.
-
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.
-
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.
-
Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.
-
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.
-
Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.
-
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone.
-
Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus.
-
Keywords of People
-
-
Chitneni, Satish K.,
Associate Professor in Radiology,
Radiology
-
Ferrari, Guido,
Professor in Surgery,
Molecular Genetics and Microbiology
-
McClain, Micah Thomas,
Associate Professor of Medicine,
Medicine, Infectious Diseases
-
Weinhold, Kent James,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Immunology